The American Psychiatric Association (APA) has updated its Privacy Policy and Terms of Use, including with new information specifically addressed to individuals in the European Economic Area. As described in the Privacy Policy and Terms of Use, this website utilizes cookies, including for the purpose of offering an optimal online experience and services tailored to your preferences.

Please read the entire Privacy Policy and Terms of Use. By closing this message, browsing this website, continuing the navigation, or otherwise continuing to use the APA's websites, you confirm that you understand and accept the terms of the Privacy Policy and Terms of Use, including the utilization of cookies.

×
Published Online:https://doi.org/10.1176/ajp.122.10.1102

Of 173 voluntary patients followed after discharge, data were obtained regarding outcome patterns during the first two years on 156. Nine postdischarge patterns were isolated. Over-all, 29 percent had outcomes considered good, 29 percent were equivocal and 41 percent poor. Concentrating on the differences within large diagnostic categories, this study demonstrates the increased predictive value of amplifying diagnoses by statements concerning age of onset and course of illness in schizophrenia. Schizophrenic patients with definite childhood asociality had the poorest outcome while those with cyclic or affective features and adult onset did best.

Among the nonschizophrenics the periodic depressives did best, while hysterical and passive-aggressive character disorders approximated the outcomes of the schizophrenics.

Longitudinal rather than cross-sectional follow-ups provide more useful information regarding evaluation of both treatment effects and the ideal treatment model. Refined outcome measures improve the usefulness of outcome categories.

Preliminary findings of third and fourth year experience postdischarge indicate the cyclic nature of certain illnesses, with some having short periods and others having long periods.

Access content

To read the fulltext, please use one of the options below to sign in or purchase access.